Is COPD associated with increased mortality and morbidity in hospitalized pneumonia? A systematic review and meta-analysis

Respirology

Volumn 20, Issue 7, 2015, Pages 1046-1054

  Jiang, Hong Li ^a   Chen, Hong Xuan ^a   Liu, Wei ^a   Fan, Tao ^a   Liu, Guan Jian ^b   Mao, Bing ^a  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

chronic obstructive pulmonary disease; meta analysis; morbidity; mortality; pneumonia

Indexed keywords

ARTIFICIAL VENTILATION; CASE CONTROL STUDY; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; COMMUNITY ACQUIRED PNEUMONIA; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; METHODOLOGY; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PUBLISHING; REVIEW; SYSTEMATIC REVIEW; COMMUNITY-ACQUIRED INFECTIONS; COMPLICATION; META ANALYSIS; PNEUMONIA; PROCEDURES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; STATISTICS AND NUMERICAL DATA;

COHORT STUDIES; COMMUNITY-ACQUIRED INFECTIONS; HUMANS; INTENSIVE CARE UNITS; LENGTH OF STAY; OUTCOME ASSESSMENT (HEALTH CARE); PNEUMONIA; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATION, ARTIFICIAL;

EID: 84941563236     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/resp.12597     Document Type: Review

References (38)

1. Musher DM, Thorner AR,. Community-acquired pneumonia. N. Engl. J. Med. 2014; 371: 1619-1628.
2. File TM Jr, Marrie TJ,. Burden of community-acquired pneumonia in North American adults. Postgrad. Med. 2010; 122: 130-141.
3. Song JH, Thamlikitkul V, Hsueh PR,. Clinical and economic burden of community-acquired pneumonia amongst adults in the Asia-Pacific region. Int. J. Antimicrob. Agents 2011; 38: 108-117.
4. Welte T, Torres A, Nathwani D,. Clinical and economic burden of community-acquired pneumonia among adults in Europe. Thorax 2012; 67: 71-79.
5. Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, Dowell SF, File TM Jr, Musher DM, Niederman MS, et al., Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin. Infect. Dis. 2007; 44 (Suppl. 2): S27-72.
6. Jackson ML, Neuzil KM, Thompson WW, Shay DK, Yu O, Hanson CA, Jackson LA,. The burden of community-acquired pneumonia in seniors: results of a population-based study. Clin. Infect. Dis. 2004; 39: 1642-1650.
7. Cilloniz C, Polverino E, Ewig S, Aliberti S, Gabarrus A, Menendez R, Mensa J, Blasi F, Torres A,. Impact of age and comorbidity on cause and outcome in community-acquired pneumonia. Chest 2013; 144: 999-1007.
8. Singh S, Amin AV, Loke YK,. Long-term use of inhaled corticosteroids and the risk of pneumonia in chronic obstructive pulmonary disease: a meta-analysis. Arch. Intern. Med. 2009; 169: 219-229.
9. Calverley PM, Anderson JA, Celli B, Ferguson GT, Jenkins C, Jones PW, Yates JC, Vestbo J,. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N. Engl. J. Med. 2007; 356: 775-789.
10. Eurich DT, Lee C, Marrie TJ, Majumdar SR,. Inhaled corticosteroids and risk of recurrent pneumonia: a population-based, nested case-control study. Clin. Infect. Dis. 2013; 57: 1138-1144.
11. Kew KM, Seniukovich A,. Inhaled steroids and risk of pneumonia for chronic obstructive pulmonary disease. Cochrane Database Syst. Rev. 2014; 3: CD010115.
12. Calverley PM, Stockley RA, Seemungal TA, Hagan G, Willits LR, Riley JH, Wedzicha JA,. Reported pneumonia in patients with COPD: findings from the INSPIRE study. Chest 2011; 139: 505-512.
13. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Abraham J, Adair T, Aggarwal R, Ahn SY, et al., Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380: 2095-2128.
14. Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M, Shibuya K, Salomon JA, Abdalla S, Aboyans V, et al., Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380: 2163-2196.
15. Molinos L, Clemente MG, Miranda B, Alvarez C, del Busto B, Cocina BR, Alvarez F, Gorostidi J, Orejas C,. Community-acquired pneumonia in patients with and without chronic obstructive pulmonary disease. J. Infect. 2009; 58: 417-424.
16. Dusemund F, Chronis J, Baty F, Albrich WC, Brutsche MH,. The outcome of community-acquired pneumonia in patients with chronic lung disease-a case-control study. Swiss Med. Wkly 2014; 144: w14013.
17. Restrepo MI, Mortensen EM, Pugh JA, Anzueto A,. COPD is associated with increased mortality in patients with community-acquired pneumonia. Eur. Respir. J. 2006; 28: 346-351.
18. Snijders D, van der Eerden M, de Graaff C, Boersma W,. The influence of COPD on mortality and severity scoring in community-acquired pneumonia. Respiration 2010; 79: 46-53.
19. Crisafulli E, Menendez R, Huerta A, Martinez R, Montull B, Clini E, Torres A,. Systemic inflammatory pattern of patients with community-acquired pneumonia with and without COPD. Chest 2013; 143: 1009-1017.
20. Liapikou A, Polverino E, Ewig S, Cilloniz C, Marcos MA, Mensa J, Bello S, Martin-Loeches I, Menendez R, Torres A,. Severity and outcomes of hospitalised community-acquired pneumonia in COPD patients. Eur. Respir. J. 2012; 39: 855-861.
21. Moher D, Liberati A, Tetzlaff J, Altman DG,. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009; 6: e1000097.
22. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB,. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283: 2008-2012.
23. Pifarre R, Falguera M, Vicente-de-Vera C, Nogues A,. Characteristics of community-acquired pneumonia in patients with chronic obstructive pulmonary disease. Respir. Med. 2007; 101: 2139-2144.
24. Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M, Tugwell P,. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2014. [Accessed 9 Jun 2014.] Available from URL: http://www.ohri.ca/programs/clinical-epidemiology/oxford.asp
25. Higgins JP, Thompson SG, Deeks JJ, Altman DG,. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557-560.
26. Rello J, Rodriguez A, Torres A, Roig J, Sole-Violan J, Garnacho-Montero J, de la Torre MV, Sirvent JM, Bodi M,. Implications of COPD in patients admitted to the intensive care unit by community-acquired pneumonia. Eur. Respir. J. 2006; 27: 1210-1216.
27. Gomez-Junyent J, Garcia-Vidal C, Viasus D, Millat-Martinez P, Simonetti A, Santos MS, Ardanuy C, Dorca J, Carratala J,. Clinical features, etiology and outcomes of community-acquired pneumonia in patients with chronic obstructive pulmonary disease. PLoS ONE 2014; 9: e105854.
28. Ruiz de Ona JM, Gomez Fernandez M, Celdran J, Puente-Maestu L,. Pneumonia in the patient with chronic obstructive pulmonary disease. Levels of severity and risk classification. Arch. Bronconeumol. 2003; 39: 101-105.
29. Ewig S, Birkner N, Strauss R, Schaefer E, Pauletzki J, Bischoff H, Schraeder P, Welte T, Hoeffken G,. New perspectives on community-acquired pneumonia in 388 406 patients. Results from a nationwide mandatory performance measurement programme in healthcare quality. Thorax 2009; 64: 1062-1069.
30. Chen D, Restrepo MI, Fine MJ, Pugh MJ, Anzueto A, Metersky ML, Nakashima B, Good C, Mortensen EM,. Observational study of inhaled corticosteroids on outcomes for COPD patients with pneumonia. Am. J. Respir. Crit. Care Med. 2011; 184: 312-316.
31. Malo de Molina R, Mortensen EM, Restrepo MI, Copeland LA, Pugh MJ, Anzueto A,. Inhaled corticosteroid use is associated with lower mortality for subjects with COPD and hospitalised with pneumonia. Eur. Respir. J. 2010; 36: 751-757.
32. Festic E, Scanlon PD,. Incident pneumonia and mortality in COPD patients. A double-effect of inhaled corticosteroids? Am. J. Respir. Crit. Care Med. 2015; 191: 141-148.
33. Loke YK, Kwok CS, Wong JM, Sankaran P, Myint PK,. Chronic obstructive pulmonary disease and mortality from pneumonia: meta-analysis. Int. J. Clin. Pract. 2013; 67: 477-487.
34. Djuric M, Povazan D, Secen N, Perin B,. Frequency and relevance of concomitant diseases in elderly patients hospitalized for community acquired pneumonia. Srp. Arh. Celok. Lek. 2009; 137: 619-626.
35. Fujiki R, Kawayama T, Ueyama T, Ichiki M, Aizawa H,. The risk factors for mortality of community-acquired pneumonia in Japan. J. Infect. Chemother. 2007; 3: 157-165.
36. Neupane B, Walter SD, Krueger P, Marrie T, Loeb M,. Predictors of inhospital mortality and re-hospitalization in older adults with community-acquired pneumonia: a prospective cohort study. BMC Geriatr. 2010; 10: 22.
37. Menendez R, Martinez R, Reyes S, Mensa J, Filella X, Marcos MA, Martinez A, Esquinas C, Ramirez P, Torres A,. Biomarkers improve mortality prediction by prognostic scales in community-acquired pneumonia. Thorax 2009; 64: 587-591.
38. Lim WS, Lewis S, Macfarlane JT,. Severity prediction rules in community acquired pneumonia: a validation study. Thorax 2000; 55: 219-223.